Brent Saunders Photo – Brent Saunders, President & CEO, Actavis
Most Dynamic Co in Growth Pharma Nov 2014

Gallery from Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue